Improved Prognosis in ALL with Modified BFM Protocols — Preliminary Results from Turkey
Intensive multiagent chemotherapy and central nervous system prophylaxis has resulted in remarkably improved event-free survival (EFS) approaching 80% in children with acute lymphoblastic leukemia (ALL) [1, 2, 3]. In contrast, prognosis of childhood ALL has remained poor with conventional treatment in our department with an overall long-term survival of 13% and an event-free interval (EFI) of 12%. Similar results have been reported from other centers in Turkey . Besides the quality of chemotherapy; supportive care measures, access to drugs, patient incompliance and socioeconomic conditions are important factors in developing countries [4, 5], leading to reluctance in the institution of intensive regimens.
KeywordsAcute Lymphoblastic Leukemia Standard Risk Intensive Regimen Central Nervous System Prophylaxis Childhood Acute Lymphoblastic Leukaemia
Unable to display preview. Download preview PDF.
- 1.Steinherz PG, Gaynon P, Miller DR et al. (1986) Improved disease free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen - a new intensive therapy protocol: a report from the Children’s Cancer Study Group. J Clin Oncol 4: 744–752PubMedGoogle Scholar
- 3.Riehm H, Gadner H, Henze G et al. (1990) Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematol Blood Transf 33: 439–450Google Scholar
- 5.Ulukutlu L, Saǧlamer L, YlldlZ İ (1987) Results of chemotherapy in acute nonlymphoblastic leukemia in children. Farmaci Terapia 4: 291–294Google Scholar
- 7.Aversa L, Garay G, Jimenez E et al. (1987) Treatment of children acute lymphoblastic leukemia (ALL) with a modified “BFM” pilot protocol [Abstract]. Proc ASCO: 156Google Scholar
- 12.Henze G, Fengler R, Hartmann R et al. (1989) Chemotherapy for bone marrow relapse of childhood acute lymphoblastic leukemia. Cancer Chern Pharmacol 24 (Suppl 1): 16–19Google Scholar
- 13.Dawson-Saunders B, Trapp RG (1990) Methods for analyzing survival data. In: Basic and clinical biostatistics. Appleton & Lange, San Mateo Norwalk, pp 186–206Google Scholar